Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Agnieszka, Krzywdzińska"'
Autor:
Aleksander Salomon-Perzyński, Joanna Barankiewicz, Marcin Machnicki, Irena Misiewicz-Krzemińska, Michał Pawlak, Sylwia Radomska, Agnieszka Krzywdzińska, Aleksandra Bluszcz, Piotr Stawiński, Małgorzata Rydzanicz, Natalia Jakacka, Iwona Solarska, Katarzyna Borg, Zofia Spyra-Górny, Tomasz Szpila, Bartosz Puła, Sebastian Grosicki, Tomasz Stokłosa, Rafał Płoski, Ewa Lech-Marańda, Jana Jakubikova, Krzysztof Jamroziak
Publikováno v:
Biomedicines, Vol 10, Iss 7, p 1674 (2022)
Clonal evolution drives treatment failure in multiple myeloma (MM). Here, we used a custom 372-gene panel to track genetic changes occurring during MM progression at different stages of the disease. A tumor-only targeted next-generation DNA sequencin
Externí odkaz:
https://doaj.org/article/157b567d61334d2ca4fc78ec78d72b72
Autor:
Eliza Zaremba-Pataj, Elżbieta Patkowska, Agnieszka Krzywdzińska, Anna Szumera-Ciećkiewicz, Justyna Chlebowska-Tuz
Publikováno v:
Journal of Hematopathology. 16:39-47
Autor:
Agnieszka Krzywdzińska, Bartosz Puła, Anna Czyż, Beata Krzymieniewska, Jolanta Kiernicka-Parulska, Anna Mierzwa, Donata Szymczak, Aneta Milanowska, Aleksandra Kiraga, Iwona Kwiecień, Joanna Zaleska, Krzysztof Jamroziak
Publikováno v:
Diagnostics, Vol 11, Iss 10, p 1872 (2021)
Minimal residual disease (MRD) status is now considered as one of the most relevant prognostic factors in multiple myeloma (MM) while MRD negativity became an important endpoint in clinical trials. Here, we report the results of the first study evalu
Externí odkaz:
https://doaj.org/article/3c78dc2043e043f59a91dd9b704d7e9a
Publikováno v:
Acta Haematologica Polonica.
Autor:
Agnieszka Krzywdzińska, Bartosz Puła, Donata Szymczak, Aneta Milanowska, Agnieszka Szeremet, Krzysztof Jamroziak
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 13; Pages: 3722
Multiple myeloma (MM) relapses are inevitable in the majority of patients, and in addition to genetic changes in the MM clone, the immune profile of the bone marrow (BM) plays a key role in this process. Biochemical progression or relapse (BR) preced
Autor:
Beata Krzymieniewska, Anna Czyż, Jolanta Kiernicka-Parulska, Iwona Kwiecień, Aneta Milanowska, Donata Szymczak, Aleksandra Kiraga, Anna Mierzwa, Agnieszka Krzywdzińska, Krzysztof Jamroziak, Bartosz Pula, Joanna Zaleska
Publikováno v:
Diagnostics
Volume 11
Issue 10
Diagnostics, Vol 11, Iss 1872, p 1872 (2021)
Volume 11
Issue 10
Diagnostics, Vol 11, Iss 1872, p 1872 (2021)
Minimal residual disease (MRD) status is now considered as one of the most relevant prognostic factors in multiple myeloma (MM) while MRD negativity became an important endpoint in clinical trials. Here, we report the results of the first study evalu
Autor:
Urszula Szlendak, Beata Krzymieniewska, Ewa Mendek-Czajkowska, Marta Rogatko-Koroś, Agnieszka Witkowska, Joanna Włodarska, Joanna Drozd-Sokołowska, Justyna Spychalska, Bożena Budziszewska, Elżbieta Patkowska, Jolanta Woźniak, Agnieszka Krzywdzińska, Sławomir Jurek, Przemysław Juszczyński, Małgorzata Jaworska, Magdalena Rosłon, Beata Gruber-Bzura, Robert Wasilewski, Beata Baran, Jerzy Windyga, Jacek Nowak
Publikováno v:
Cytokine. 150
Paroxysmal nocturnal hemoglobinuria (PNH) is a clonal non-malignant disease in which hematopoietic cell apoptosis may play an important pathophysiological role. Previous studies of the content of phosphatidylinositol (3,4,5)-trisphosphate (PI(3,4,5)P
Autor:
Aleksander, Salomon-Perzyński, Aleksandra, Bluszcz, Agnieszka, Krzywdzińska, Zofia, Spyra-Górny, Natalia, Jakacka, Joanna, Barankiewicz, Katarzyna, Borg, Iwona, Solarska, Tomasz, Szpila, Bartosz, Puła, Sebastian, Grosicki, Krzysztof, Jamroziak
Publikováno v:
Polish archives of internal medicine. 130(6)
Prognosis of patients with newly diagnosed multiple myeloma (MM), a third most common hematological cancer, is dependent on baseline cytogenetics. However, little is known about the prognostic significance of cytogenetic evolution (CE) at the time be
Autor:
Iwona Solarska, Aleksandra Bluszcz, Katarzyna Borg, Sebastian Grosicki, Zofia Spyra-Gorny, Krzysztof Jamroziak, Bartosz Pula, Natalia Jakacka, Tomasz Szpila, Joanna Barankiewicz, Aleksander Salomon-Perzyński, Agnieszka Krzywdzińska
Publikováno v:
Polish Archives of Internal Medicine.
Introduction Prognosis of patients with newly diagnosed multiple myeloma (MM), a third most common hematological cancer, is dependent on baseline cytogenetics. However, little is known about the prognostic significance of cytogenetic evolution (CE) a
Publikováno v:
Hematologia. 9:196-201
Light chain amyloidosis (AL amyloidosis) is a systemic disease leading to organ damage due to deposition of amyloid fibers arising from accumulation of amyloid precursors – monoclonal immunoglobulin light chains produced by clonal bone marrow plasm